GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,192,000 | +58.7% | 115,638 | -3.1% | 3.74% | +46.2% |
| Q3 2019 | $5,792,000 | -3.9% | 119,372 | +4.2% | 2.56% | +7.9% |
| Q2 2019 | $6,026,000 | -5.6% | 114,562 | -5.0% | 2.37% | +8.3% |
| Q1 2019 | $6,383,000 | +102.2% | 120,594 | +56.8% | 2.19% | +120.5% |
| Q4 2018 | $3,157,000 | -1.8% | 76,899 | -9.1% | 0.99% | +10.2% |
| Q3 2018 | $3,214,000 | -40.1% | 84,579 | -28.8% | 0.90% | -49.3% |
| Q2 2018 | $5,369,000 | +116.2% | 118,775 | +131.0% | 1.78% | +45.9% |
| Q1 2018 | $2,483,000 | +23.0% | 51,412 | +0.2% | 1.22% | +40.3% |
| Q4 2017 | $2,019,000 | – | 51,301 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |